Novus Diagnostics Ltd. Filing for TRINITY BIOTECH PLC

Novus Diagnostics Ltd. has filed a Schedule 13G, reporting beneficial ownership of 1,119,988 American Depositary Shares (ADS) of TRINITY BIOTECH PLC, representing 5.99% of the total outstanding ADSs. Each ADS corresponds to four Class 'A' Ordinary Shares. This filing indicates that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer. The filing was made on March 6, 2026, with an event date of December 23, 2025. Novus Diagnostics Ltd. has sole voting and dispositive power over these securities.